Jul 9, 2026 09:37AM
May 18, 2026 04:46PM
Apr 30, 2026 06:22AM
Apr 30, 2026 06:00AM
Feb 5, 2026 07:24AM
Nov 20, 2025 07:45AM
Nov 17, 2025 06:26AM OS Therapies Incorporated (OSTX) Reports Q3 Loss of $0.21
Aug 4, 2025 04:33PM
Jul 3, 2025 07:41AM
Jun 30, 2025 06:02AM
Jun 24, 2025 07:41AM
Jun 10, 2025 07:40AM
Jun 6, 2025 07:31AM
May 16, 2025 04:34PM OS Therapies Incorporated (OSTX) Reports Q1 Loss of $0.18
May 7, 2025 08:45AM
Apr 22, 2025 07:41AM
Apr 22, 2025 07:34AM
Apr 9, 2025 07:40AM
Mar 31, 2025 07:40AM
Feb 24, 2025 07:25AM
Feb 20, 2025 05:54AM OS Therapies (OSTX) Receives Patent Notice of Allowance from U.S. Patent & Trademark Office Covering Commercial Manufacturing of OST-HER2
Feb 14, 2025 07:36AM
Feb 4, 2025 07:33AM
Jan 15, 2025 07:45AM
Dec 31, 2024 03:38PM
Dec 26, 2024 10:03AM
Dec 24, 2024 09:32AM
Oct 28, 2024 04:44PM OS Therapies (OSTX) Appoints Avril McKean Dieser and Olivier R. Jarry to its Board
Sep 13, 2024 08:09AM
Sep 3, 2024 07:17AM
Aug 29, 2024 07:53AM
Aug 22, 2024 01:01PM
Aug 2, 2024 08:56AM
Jul 24, 2024 10:50AM

423,029 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All